See All Slides - tctmd.com

Slides

Presentation TCT 2013

TCT-45. Use of drug-eluting stent (DES) with bioresorbable polymer in patients with ST-segment elevation myocardial infarction (STEMI) - Mid- and long-term clinical outcomes

Presenter: Andres I?iguez

October 29, 2013

Presentation TCT 2013

Effective Antegrade Cardiac Gene Therapy with VEGF-B167 for Pacing-induced Dilated Cardiomyopathy in a Pre-clinical Large Animal Model of Heart Failure

Presenter: Felix Woitek

October 29, 2013

Presentation

Is There Really a Problem? Revascularization of Calcified Coronary Lesions

Presenter: Philippe Généreux

October 29, 2013

Presentation TCT 2013

Profile of Patients with Atrial Fibrillation in 2013: From the Highly Symptomatic Athlete to the Asymptomatic 85-Year-Old

Presenter: Mintu Turakhia

October 29, 2013

Presentation TCT 2013

TCT-67. The First Establishment of Early Healing Profile, 9-month Neointimal Growth, and 24 Months Outcomes of the Dual Therapy Endothelial Progenitor Cell Capturing...

Presenter: Stephen Lee

October 29, 2013

Presentation TCT 2013

How Do I Assess an Intermediate Lesion?

Presenter: William Fearon

October 29, 2013

Presentation TCT 2013

Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II)

Presenter: Stephan Windecker

October 29, 2013

Presentation TCT 2013

TCT-9. Racial Disparity With On-Treatment Platelet Reactivity In Patients Undergoing Percutaneous Coronary Intervention

Presenter: Iakshmana Pendyala

October 29, 2013

Presentation

Case 1: A Bleeding Patient Post-DES

Presenter: David Kandzari

October 29, 2013

Presentation TCT 2013

Scope of the Problem

Presenter: Philippe Généreux

October 29, 2013

Advertisement

Slides

TCT-45. Use of drug-eluting stent (DES) with bioresorbable polymer in patients with ST-segment elevation myocardial infarction (STEMI) - Mid- and long-term clinical outcomes

Effective Antegrade Cardiac Gene Therapy with VEGF-B167 for Pacing-induced Dilated Cardiomyopathy in a Pre-clinical Large Animal Model of Heart Failure

Is There Really a Problem? Revascularization of Calcified Coronary Lesions

Profile of Patients with Atrial Fibrillation in 2013: From the Highly Symptomatic Athlete to the Asymptomatic 85-Year-Old

TCT-67. The First Establishment of Early Healing Profile, 9-month Neointimal Growth, and 24 Months Outcomes of the Dual Therapy Endothelial Progenitor Cell Capturing...

How Do I Assess an Intermediate Lesion?

Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II)

TCT-9. Racial Disparity With On-Treatment Platelet Reactivity In Patients Undergoing Percutaneous Coronary Intervention

Case 1: A Bleeding Patient Post-DES

Scope of the Problem

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content